Du J, Wei R, Jiang S, Jiang H, et al. CAR-T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance status. Am J Hematol 2022;97:933-941.
PMID: 35488407